Hemo Organic Limited Announces Independent Director Resignation Under Regulation 30

2 min read     Updated on 01 Apr 2026, 12:06 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hemo Organic Limited has formally notified BSE Limited about the resignation of Independent Director Mr. Deepak Ashokkumar Rochani (DIN: 11041560), effective from March 31, 2026. The resignation was attributed to pre-occupation and other professional commitments, with comprehensive regulatory documentation provided under SEBI Regulation 30.

powered bylight_fuzz_icon
36526812

*this image is generated using AI for illustrative purposes only.

Hemo Organic Limited has formally announced the resignation of Independent Director Mr. Deepak Ashokkumar Rochani, effective from the closure of business hours on March 31, 2026. The company submitted the required intimation to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignation Details

Mr. Deepak Ashokkumar Rochani (DIN: 11041560) submitted his resignation from the position of Independent Director due to pre-occupation and other professional commitments. The resignation was processed on March 31, 2026, with Managing Director Vishwambar Kameshwar Singh (DIN: 09822587) signing the official communication to BSE Limited.

Parameter: Details
Director Name: Mr. Deepak Ashokkumar Rochani
DIN: 11041560
Position: Independent Director
Effective Date: March 31, 2026
Reason: Pre-occupation and professional commitments
Board Committees: 3

In his resignation letter, Mr. Rochani confirmed that there are no other material reasons for his departure beyond those mentioned. He expressed gratitude to the Board of Directors and colleagues for their support during his tenure.

Regulatory Compliance and Documentation

The company provided comprehensive documentation as required under SEBI regulations, including the complete resignation letter and detailed annexure. The filing was made pursuant to Regulation 30 read with SEBI circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Compliance Aspect: Details
Regulation: SEBI Regulation 30
Scrip Code: 524590
Scrip Symbol: HEMORGANIC
ISIN: INE422G01015
Filing Date: March 31, 2026

Committee Impact and Reconstitution

Following Mr. Rochani's resignation, he stepped down from all board committees where he served as Chairman or Member. The company had previously reconstituted all three board committees with effect from April 1, 2026, ensuring continuity in governance structure.

Current Committee Structure

Committee: Chairman Members
Audit Committee: Ms. Rina Kumari Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh
Nomination and Remuneration: Ms. Rina Kumari Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh
Stakeholders Grievance: Ms. Rina Kumari Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh

The reconstituted committees maintain consistent membership across all three committees, with Ms. Rina Kumari serving as Chairman and the same composition of members ensuring streamlined governance operations.

Historical Stock Returns for Hemo Organic

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-9.24%-30.32%+9.62%+26.39%-23.95%

Will Hemo Organic recruit a new independent director to maintain board diversity and independence ratios?

How might the concentration of committee leadership under Ms. Rina Kumari affect governance oversight and decision-making processes?

Could this resignation signal broader governance challenges or strategic shifts within Hemo Organic's management structure?

Hemo Organic Limited Allots 34 Lakh Convertible Warrants and Relocates Registered Office

2 min read     Updated on 26 Feb 2026, 03:06 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Hemo Organic Limited's board approved allotment of 34,00,000 convertible warrants at Rs. 12.50 each to two non-promoter entities - Vacro Enterprises Private Limited and Qmin Realities Private Limited. The warrants are convertible within 18 months and will double the company's paid-up share capital from Rs. 3,46,59,000 to Rs. 6,86,59,000 upon full conversion. The company also relocated its registered office within Ahmedabad effective February 26, 2026.

powered bylight_fuzz_icon
33644201

*this image is generated using AI for illustrative purposes only.

Hemo Organic Limited announced significant corporate developments following its board meeting held on February 26, 2026. The company's board approved the allotment of convertible warrants and relocation of its registered office within Ahmedabad.

Convertible Warrants Allotment

The board approved the allotment of 34,00,000 convertible warrants to non-promoter entities at Rs. 12.50 per warrant, including a premium of Rs. 2.50 each. The warrants carry a face value of Rs. 10.00 each and are convertible within 18 months from the allotment date.

Parameter: Details
Total Warrants Allotted: 34,00,000
Issue Price: Rs. 12.50 per warrant
Face Value: Rs. 10.00 per warrant
Premium: Rs. 2.50 per warrant
Conversion Period: 18 months
Category: Non-Promoter

The allotment was made on a preferential basis in accordance with Chapter V of SEBI (ICDR) Regulations, 2018. Each warrant is convertible into one fully paid-up equity share upon payment of the remaining 75.00% of the issue price.

Allottee Details

The warrants were allocated equally between two private limited companies:

Sr. No. Allottee Name Warrants Allotted 25% Consideration (Rs.)
1 Vacro Enterprises Private Limited 17,00,000 53,12,500
2 Qmin Realities Private Limited 17,00,000 53,12,500
Total 34,00,000 1,06,25,000

Impact on Share Capital

Upon full conversion of the warrants, the company's capital structure will undergo significant expansion:

Parameter: Current Post-Conversion
Paid-up Share Capital: Rs. 3,46,59,000 Rs. 6,86,59,000
Number of Equity Shares: 34,65,900 68,65,900
Face Value per Share: Rs. 10.00 Rs. 10.00

The new equity shares will rank pari-passu with existing equity shares, ensuring equal rights and privileges for all shareholders.

Registered Office Relocation

The board also approved shifting the company's registered office within Ahmedabad. The new address is Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350. The relocation became effective from February 26, 2026.

The board meeting commenced at 02:15 P.M. and concluded at 02:45 P.M. on February 26, 2026, with Managing Director Vishwambar Kameshwar Singh overseeing the proceedings.

Historical Stock Returns for Hemo Organic

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-9.24%-30.32%+9.62%+26.39%-23.95%

More News on Hemo Organic

1 Year Returns:+26.39%